Medifast Q4 revenue down 38% to $119M; EPS $0.07; guides Q1 loss

MEDIFAST INC

2024-FY EPS reported $0.19 revenue$602,463,000

Q4 revenue $119M (-37.7% YoY); active earning coaches 27,100 (-34.1% YoY).
Net income $0.8M ($0.07 diluted EPS); non-GAAP adjusted EPS $0.10.
Full year 2024 revenue $602.5M (-43.8%); net income $2.1M ($0.19 EPS).
Q1 2025 guidance: revenue $100-$120M, EPS loss $0.50 to $0.00 per share.
Cash & investments $162.3M, no debt; cites GLP-1 market headwinds.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.